Change in the total number of shares and votes in Recipharm AB (publ)

In July 2015, the number of shares in Recipharm AB (publ) (“Recipharm”) has
increased by 560,000 shares of series D of which 60,000 shares have been
converted into 60,000 shares of series B. All these new shares are currently
held by Recipharm for the purpose of securing delivery of shares of series B to
participants of Recipharm’s share saving programmes resolved by the Annual
General Meeting in 2014 and 2015. The shares of series D will be converted into
shares of series B prior to delivery of shares to participants under the share
saving programmes.

As of 31 July 2015, the total number of shares in Recipharm amounts to
46 325 256, divided into 12 685 716 shares of series A, 33,139,540 shares of
series B and 500 000 shares of series D. The total number of votes in Recipharm
as of 31 July 2015 amounts to 160,496,700.

For further information please visit www.recipharm.com or contact:

Thomas Eldered, CEO, telephone: +46 8 602 52 10

Björn Westberg, CFO, ir@recipharm.com, telephone: +46 8 602 46 20

This information is published in accordance with Chapter 4, Section 9 of the
Swedish Financial Instruments Trading Act (SFS 1991:980).This information was
submitted for publication on 31 July 2015, at 08:00 am CET.
Recipharm AB (publ)
Corporate identity number 556498-8425
Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52
00, Fax 46 8 81 87 03
www.recipharm.com